These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38590988)

  • 21. Clinical Outcomes of Left Atrial Appendage Occlusion Versus Switch of Direct Oral Antcoagulant in Atrial Fibrillation: A Territory-Wide Retrospective Analysis.
    Ng AK; Ng PY; Ip A; Fung RC; Chui SF; Siu CW; Yan BP
    J Am Heart Assoc; 2023 Oct; 12(20):e029421. PubMed ID: 37804191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical follow-up of left atrial appendage occlusion in patients with atrial fibrillation ineligible of oral anticoagulation treatment-a systematic review and meta-analysis.
    Labori F; Bonander C; Persson J; Svensson M
    J Interv Card Electrophysiol; 2021 Aug; 61(2):215-225. PubMed ID: 33580847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
    Onalan O; Crystal E
    Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous devices for left atrial appendage occlusion: A contemporary review.
    Moussa Pacha H; Al-Khadra Y; Soud M; Darmoch F; Moussa Pacha A; Alraies MC
    World J Cardiol; 2019 Feb; 11(2):57-70. PubMed ID: 30820276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence.
    Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D
    J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Decision Analysis of Percutaneous Left Atrial Appendage Occlusion Relative to Novel and Traditional Oral Anticoagulation for Stroke Prevention in Patients with New-Onset Atrial Fibrillation.
    Micieli A; Wijeysundera HC; Qiu F; Atzema CL; Singh SM
    Med Decis Making; 2016 Apr; 36(3):366-74. PubMed ID: 26139448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion.
    Ge H; Zhang C; Qiao ZQ; Hao ZY; Li Z; Gu ZC; Jiang LS; He B; Pu J
    Sci Prog; 2022; 105(3):368504221113194. PubMed ID: 35849447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage.
    Di Biase L; Mohanty S; Trivedi C; Romero J; Natale V; Briceno D; Gadiyaram V; Couts L; Gianni C; Al-Ahmad A; Burkhardt JD; Gallinghouse GJ; Horton R; Hranitzky PM; Sanchez JE; Natale A
    J Am Coll Cardiol; 2019 Aug; 74(8):1019-1028. PubMed ID: 31439209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies.
    Li X; Wen SN; Li SN; Bai R; Liu N; Feng L; Ruan YF; Du X; Dong JZ; Ma CS
    Heart Rhythm; 2016 Jun; 13(6):1203-14. PubMed ID: 26724488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
    Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
    Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 34187638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries.
    Wang W; Chen LY; Walker RF; Alonso A; Norby FL; Lakshminarayan K; Lutsey PL
    Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5786. PubMed ID: 38565524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of Left Atrial Appendage Occlusion in Left Atrial Appendage Thrombus: A Systematic Review.
    Sharma SP; Cheng J; Turagam MK; Gopinathannair R; Horton R; Lam YY; Tarantini G; D'Amico G; Freixa Rofastes X; Lange M; Natale A; Lakkireddy DR
    JACC Clin Electrophysiol; 2020 Apr; 6(4):414-424. PubMed ID: 32327075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary findings on left atrial appendage occlusion simulations applying different endocardial devices.
    D'Alessandro N; Falanga M; Masci A; Severi S; Corsi C
    Front Cardiovasc Med; 2023; 10():1067964. PubMed ID: 36891242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis.
    Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG
    JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
    Raghuram P; Pavithran S; Sivakumar K
    Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and feasibility of combined atrial fibrillation ablation and left atrial appendage occlusion after left atrial appendage electrical isolation.
    Kita K; Carlson S; Huntsinger M; Tun H; Sohn J; Doshi RN
    J Interv Card Electrophysiol; 2020 Jan; 57(1):43-55. PubMed ID: 31377973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ablation for Atrial Fibrillation Combined With Left Atrial Appendage Closure.
    Alipour A; Swaans MJ; van Dijk VF; Balt JC; Post MC; Bosschaert MAR; Rensing BJ; Reddy VY; Boersma LVA
    JACC Clin Electrophysiol; 2015 Dec; 1(6):486-495. PubMed ID: 29759402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous left atrial appendage occlusion: impact on left atrial deformation indices.
    Dippenaar AP; Saaiman JA; Heradien MJ; Brink PA; van der Bijl P
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):359-367. PubMed ID: 36322264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.